This paper shows analysis of the association of the 802C>T polymorphism of the NOD2/CARD15 gene with the occurrence of the chronic inflammation of the gastric mucosa associated with the Helicobacter pylori infections, development of intestinal metaplasia and dysplasia and, in the result of this, gastric cancer. Genomic DNA samples were extracted from paraffin blocks of gastric mucosal biopsies and from peripheral blood. H. pylori infection was confirmed by histological analysis and urease test. Pyrosequencing of 802C>T polymorphism of the NOD2/CARD15 gene was performed for H. pylori infected patients (131) and population group (100). Analysis of the NOD2/CARD15 gene showed that frequency of the T allele was significantly higher (32.8%) in the group of patients in comparison with the population group (18.1%), with the relative risk of 1.8. In the patient group, the frequency of the CC genotype was 51.1%, CT 32.1% and TT 16.8% (relative risk: 0.7, 1.1 and 4.2, respectively), while in the population group it was 69.0%, 25.7% and 5.3% (relative risk: 1.0, 0.9 and 1.3, respectively). The increasing frequency of the T allele and CT and TT genotypes in the patients with increasingly deeper changes in the gastric mucosa becomes apparent. Our findings suggest that polymorphism 802C>T is associated with changes in gastric mucosa and plays a significant role in the initiation and the progression of carcinogenesis. The number of observed mutations in gastric mucosa correlated with severity of disease.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.yexmp.2010.03.003 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
NOD2 and Crohn's Disease Clinical Practice: From Epidemiology to Diagnosis and Therapy, Rewired.
Inflamm Bowel Dis
April 2024
Department of Medicine and Surgery, University of Parma, Parma, Italy.
Crohn's disease (CD) is a chronic inflammatory bowel disease with a multifactorial pathogenesis involving environmental and genetic factors. Since the late 20th century, the discovery of the first susceptibility gene (NOD2, previously referred to as CARD15) for CD has paved the way for further investigations into the correlations between clinical features and genetics, and its potential impact on clinical practice has fueled the research in the last 2 decades. Recent therapeutic advancements involving novel biologic drugs and small molecules have shifted inflammatory bowel disease management from a disease-centered to a patient-centric approach.
View Article and Find Full Text PDFThe Potential Role of NOD2/CARD15 Genotype as a Prognostic Indicator for Bone Marrow Transplantation Outcomes in Patients With Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia: A Systematic Review.
Cureus
January 2024
Pharmacology and Therapeutics, Saint James School of Medicine, Arnos Vale, VCT.
Hematopoietic stem-cell transplantation (HSCT) has emerged as a groundbreaking therapeutic option for acute myeloid leukemia (AML) and specific subtypes of acute lymphoblastic leukemia (ALL). The prognostic significance of the NOD2/CARD15 gene has been explored alongside various factors, encompassing diverse patient cohorts and gene variants. Siblings and unrelated donors used for stem cell transplantation exhibit significant associations between their genetic variations and graft-versus-host disease incidence.
View Article and Find Full Text PDFNOD2 Polymorphisms May Direct a Crohn Disease Phenotype in Patients With Very Early-Onset Inflammatory Bowel Disease.
J Pediatr Gastroenterol Nutr
December 2023
From the Department of Pediatric Gastroenterology, Hepatology, and Nutrition, Baylor College of Medicine, Texas Children's Hospital, Houston, TX.
Article Synopsis
- - NOD2/CARD15 is known as a key gene for Crohn's disease, especially in adult cases, and its genetic variations are linked to pediatric Crohn's as well.
- - In a study comparing 10 pediatric patients with NOD2 variations (NOD2 +) to 16 without (NOD2 -), the NOD2 + group showed significantly higher instances of Crohn's-like symptoms, stunted growth, and joint issues.
- - The results suggest that NOD2 polymorphisms could lead to specific health challenges in very early-onset inflammatory bowel disease, indicating the need for further research to inform targeted treatments.
An autoinflammatory syndrome with compound heterozygous and / gene mutations successfully treated with tocilizumab.
Rheumatol Adv Pract
May 2022
Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY.
Detection of mutations in gene in Arab patients with Crohn's disease.
Saudi J Gastroenterol
October 2021
Department of Research Core Facility, OMICS Research Unit, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait.
Article Synopsis
- - The study investigates the connection between mutations in the NOD2/CARD15 gene and Crohn's disease (CD) among Arabs in Kuwait, focusing on four specific mutations.
- - Researchers analyzed DNA from 103 CD patients and 100 control subjects, discovering that mutations Pro268Ser (SNP5) and Gly908Arg (SNP12) showed differing associations with CD risk.
- - Results revealed that the Gly908Arg mutation increases susceptibility to CD, while the Pro268Ser mutation appears to provide some protective effect against the disease.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!